Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model
Introduction
Successful implant therapy depends on the achievement of favorable implant stability, which can be divided into primary stability and secondary stability or osseointegration 9 . Both primary stability and osseointegration are affected by different factors, including bone quantity and quality, implant design, and surgical protocols 24 . In particular, the most important factor is the condition of the bone at the site of implant placement 19 . Primary stability decreases at sites with a low bone density, which may result in implant failure 25 .
Osteoporosis is a skeletal disease that causes the systematic loss of bone regarding density and quantity. As mentioned above, the condition of the bone at the implant placement site is strongly Currently, the intermittent administration of parathyroid hormone (PTH) for enhancing bone formation and improving bone quantity is clinically approved. Some animal studies have reported that intermittent PTH administration is effective in promoting bone remodeling and increasing the trabecular bone mass 10, 11 . PTH affects cancellous bone remodeling by promoting the formation of osteoblasts and suppressing their apoptosis 2, 16 . Furthermore, it increases the thickness of not only trabecular bone, but also cortical bone 15 . Therefore, intermittent PTH administration can be effective in improving the bone density at the implant placement site and achieving favorable primary stability and osseointegration in patients with severe osteoporosis, including that induced by glucocorticoids. Corsini, et al. 5 (2008) reported that intermittent PTH administration enhanced secondary stability in normal healthy rabbits. Almagro, et al. 1 (2013) reported that osseointegration could be improved by intermittent PTH administration in rabbit models with osteoporosis.
In these studies, however, intermittent PTH administration was initiated after implant placement; furthermore, only secondary implant stability or osseointegration was evaluated. Therefore, the effects on primary stability remained unclear, considering the bone quality at the implant placement site was not improved by prior intermittent PTH administration.
On the other hand, our previous study assessed 
Animals and experimental design
Fifteen 17-week-old female New Zealand White rabbits (3.0-3.5 kg body weight) were used in this study. The experimental design is shown in Figure   1 . All animals initially underwent ovariectomy, and, 
Measurement of the implant stability quotient (ISQ)
Resonance frequency analysis (RFA) was performed using an Osstell device (Osstell AB, Gothenburg, The socket is created in the distal epiphysis (knee joint) of the left femur. After the knee joint was exposed, an implant surgical system with a rotary speed not exceeding 800 rpm was used for consecutive applications of a 2.0-mm round drill, 2.0-mm twist drill, 3.0-mm pilot drill, 3.0-mm twist drill, and countersink drill. Following the socket preparation procedures, implants were inserted until the color indicator was level with the bone ridge Measurements were performed three times from two different directions, and the values obtained for each implant were averaged. All measurements were obtained using procedures described in a previous study 6, 7 .
Histological analysis than the values for both the control (68.1±5.1) and PTH1 (69.4±8.3) groups (p<0.05).
Histological observations and histomorphometric analyses Figure 7 shows the findings of histological evaluation. In the control and PTH1 specimens, the trabecular bone structure was limited to the upper portion around the implant socket; the lower portion PTH2 specimen, on the other hand, trabecular bone structure was detected in the upper and lower portions around the implant socket (near the marrow). suppressing bone formation through the inhibition of osteoblastogenesis and promotion of osteoblast and osteocyte apoptosis 2, 16 . In our study, ISQ . adaptation between the implant surface and the surrounding bone 27 . In this study, ISQ values for Several studies have reported that the bone condition measurements are related to the supported length of the bone stiffness around the implant socket 8, 12, 18, 22 .
In our study, the ISQ value 4 weeks after implant placement was significantly higher for the PTH2 group than for the other two groups. Histological assessments showed a thicker and more trabecular bone in the PTH2 specimens than in the PTH1 and control specimens. In the PTH2 group, newly formed bone was detected not only in the upper portion but also in the lower portion near the bone marrow. In addition, the implant socket could be clearly visualized in this group. In the other two groups, the newly formed bone was limited to the upper portion around the implant socket. Histomorphological analyses indicated that the bone area around the implant socket the PTH1 and control groups. The ISQ is considered to increase in condition to the stiffness of the boneimplant interface 13, 26 . Also, Miyamoto, et al. 20 correlation detected between the ISQ and bone cortical thickness. This result was in accordance with the ISQ values at 4 weeks, which were high for the PTH group because of new bone formation around the placed implants, caused by the effects of PTH administration during the healing period. The aspects consider that intermittent PTH administration after implant placement accelerate bone formation around the placed implant enhances osteoblast activity. Thus, the secondary stability of PTH2 group was increased. We the PTH1 and PTH2 groups at 2 weeks after implant placement. Castañeda, et al. 3 (2008) reported that the effects of glucocorticoids persisted for more than 3 months after discontinuation in a rabbit study. the appropriate dosage of PTH for achieving such an effect 5, 29 . In our study, the PTH dose rate was set at is within the range used for in vivo rabbit studies 21 .
In conclusion, the results of our study suggest that continual intermittent PTH administration is effective for achieving favorable primary and secondary stability in the presence of osteoporosis. It is the authors' intention to conduct further studies comparing normal healthy models to investigate the detailed effects of PTH on implant stability.
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